10% Owner Files Intent to Sell Nearly $1 Million in Tenaya Therapeutics Shares
TNYA sits 73% above its 52-week low of $0.36.
Summary
A major 10% institutional investor, COLUMN GROUP III-A, LP, has filed a Form 144 to sell an additional $985,362 in Tenaya Therapeutics common stock, continuing a pattern of significant share dispositions.
Key Events · Ownership and Investor Activity · TNYA
-
Intent to Sell Shares
COLUMN GROUP III-A, LP, a 10% stockholder, filed a Form 144 to sell 1,591,090 shares of common stock, valued at approximately $985,362.04.
-
Continuation of Recent Sales
This filing follows previous dispositions by The Column Group and its affiliates, including over $3 million in sales reported on February 12, 2026, and other Form 144 filings in the past week, indicating an ongoing distribution strategy.
-
Filer's Relationship
The filer, COLUMN GROUP III-A, LP, is identified as a 10% stockholder of Tenaya Therapeutics, Inc.
Analysis · TNYA · Life Sciences
COLUMN GROUP III-A, LP, a 10% stockholder, has filed a Form 144 indicating its intent to sell approximately $985,362 worth of common stock. This follows a series of recent dispositions by The Column Group and its affiliates, including over $3 million in sales reported on February 12, 2026, and previous Form 144 filings. This continued intent to sell by a major institutional investor suggests ongoing distribution and could exert downward pressure on the stock.
At the time of this filing, TNYA was trading at $0.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $134.1M. The 52-week trading range was $0.36 to $2.35. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.